Article
MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - 1 May 2016
Lien Huang-Chun, Huang Chiun-Sheng, Yang Ya-Wen, Jeng Yung-Ming
Abstract excerpt
Spindle neoplasms of the breast (SNB) primarily include metaplastic breast carcinoma (MBC), phyllodes tumour (PT), fibromatosis and primary nonspecific sarcoma (PNS). Mutations in MED12 exon 2 have been reported in PTs. Because spindle tumour components are shared by SNB, we assessed the diagnostic use of MED12 exon 2 mutation in SNB. We investigated MED12 exon 2 mutations in a total of 91 samples of SNB,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
